Irena Frydecka

Irena Frydecka

UNVERIFIED PROFILE

Are you Irena Frydecka?   Register this Author

Register author
Irena Frydecka

Irena Frydecka

Publications by authors named "Irena Frydecka"

Are you Irena Frydecka?   Register this Author

51Publications

547Reads

30Profile Views

The Influence of Genetic Variations in the Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

J Immunol Res 2018 7;2018:3826989. Epub 2018 Feb 7.

Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, R Weigl 12, 53-114 Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/3826989DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821961PMC
August 2018

CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.

Endocrine 2017 Jan 16;55(1):186-199. Epub 2016 Sep 16.

Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, L. Pasteur 4, Wroclaw, 50-367, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-016-1096-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225215PMC
January 2017

Association of 3' nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population.

Urol Oncol 2016 09 24;34(9):419.e13-9. Epub 2016 May 24.

Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, Wroclaw, Poland; Department of Urology and Oncological Urology, Wroclaw Medical University, Wroclaw, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.04.010DOI Listing
September 2016

CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia.

Clin Exp Med 2016 Aug 24;16(3):317-32. Epub 2015 May 24.

Laboratory of Immunopathology, Department of Experimental Therapy, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114, Wrocław, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10238-015-0360-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969362PMC
August 2016

Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibody.

Tumour Biol 2016 Mar 21;37(3):4143-57. Epub 2015 Oct 21.

Laboratory of Immunopathology, Department of Experimental Therapy, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114, Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-015-4217-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844645PMC
March 2016

A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.

Immunogenetics 2015 Jun 5;67(5-6):295-304. Epub 2015 May 5.

Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Science, R. Weigl 12, 53-114, Wroclaw, Poland,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00251-015-0840-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427628PMC
June 2015

Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation.

Immunol Lett 2015 May 1;165(1):52-9. Epub 2015 Apr 1.

Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, R Weigl St 12, Wroclaw 53-114, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2015.03.011DOI Listing
May 2015

Gene polymorphisms of novel immunotolerant molecule BTLA: distribution of alleles, genotypes and haplotypes in Polish Caucasian population.

Arch Immunol Ther Exp (Warsz) 2015 Feb 3;63(1):73-8. Epub 2014 Sep 3.

Department of Experimental Therapy, Institute of Immunology and Experimental Therapy, Polish Academy of Science, Weigla 12, 53-114, Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00005-014-0300-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289528PMC
February 2015

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.

Hum Immunol 2014 Jun 19;75(6):508-13. Epub 2014 Apr 19.

Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2014.04.002DOI Listing
June 2014

Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement.

Rheumatol Int 2014 Feb 13;34(2):243-53. Epub 2013 Nov 13.

Department of Immunopathology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114, Wrocław, Poland,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-013-2895-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904036PMC
February 2014

PPARg2 Ala¹² variant protects against Graves' orbitopathy and modulates the course of the disease.

Immunogenetics 2013 Jul 21;65(7):493-500. Epub 2013 Apr 21.

Department of Experimental Therapy, L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114 Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00251-013-0702-0DOI Listing
July 2013

rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?

Br J Haematol 2013 Jul 14;162(2):221-8. Epub 2013 May 14.

Division of Genetics and Epidemiology, Molecular and Population Genetics, Institute of Cancer Research, Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12366DOI Listing
July 2013

KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population.

Hum Immunol 2012 Sep 23;73(9):927-31. Epub 2012 Jul 23.

Laboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S019888591200488
Publisher Site
http://dx.doi.org/10.1016/j.humimm.2012.07.323DOI Listing
September 2012

ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population.

Folia Histochem Cytobiol 2011 ;49(1):49-54

Institute of Immunology and Experimental Therapy, Polish Academy of Science, Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/fhc.2011.0008DOI Listing
October 2011

CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.

Hum Immunol 2011 Oct 24;72(10):947-54. Epub 2011 May 24.

Department of Experimental Therapy, Institute of Immunology and Experimental Therapy, Polish Academy of Science, Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2011.05.010DOI Listing
October 2011

Zeta chain expression in T and NK cells in peripheral blood of children with nephrotic syndrome.

Pediatr Nephrol 2010 Jan 15;25(1):119-27. Epub 2009 Oct 15.

Department of Pediatric Nephrology, Wrocław Medical University, M. Curie-Sklodowskiej 50/52, 50-369 Wrocław, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00467-009-1305-8DOI Listing
January 2010

Is cyclin D2 a marker of B-cLL cell activation?

Oncol Res 2009 ;18(2-3):127-31

Department of Experimental Therapy, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3727/096504009789954663DOI Listing
January 2010

Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.

Eur J Endocrinol 2009 Nov 4;161(5):787-93. Epub 2009 Sep 4.

Department of Endocrinology, Diabetology, and Isotope Therapy, Medical University, ul. Pasteura 4, 50-367 Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-09-0600DOI Listing
November 2009

Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer.

Oncol Rep 2009 Jan;21(1):173-84

Department of Experimental Therapy, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.

View Article

Download full-text PDF

Source
January 2009

The significance of Treg cells in defective tumor immunity.

Arch Immunol Ther Exp (Warsz) 2008 May-Jun;56(3):181-91. Epub 2008 May 30.

Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00005-008-0018-1DOI Listing
September 2008

CD28 downregulation on CD4+ T cells is associated with age of kidney transplant recipient.

Transpl Int 2008 Jul 13;21(7):661-8. Epub 2008 Mar 13.

Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1432-2277.2008.00663.x
Publisher Site
http://dx.doi.org/10.1111/j.1432-2277.2008.00663.xDOI Listing
July 2008

Alterations in the expression of signal-transducing CD3 zeta chain in T cells from patients with chronic inflammatory/autoimmune diseases.

Arch Immunol Ther Exp (Warsz) 2007 Nov-Dec;55(6):373-86. Epub 2007 Dec 3.

Laboratory of Immunopathology, Department of Experimental Therapy, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114, Wrocław, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00005-007-0042-6DOI Listing
January 2008

[Variable expression of CD28 costimulatory molecule and CTLA4 inhibitory molecule on peripheral blood CD4+ cells in kidney allograft recipients with and without acute graft rejection].

Pol Merkur Lekarski 2006 Aug;21(122):157-9; discussion 160

Akademia Medyczna we Wrocławiu, Katedra i Klinika Nefrologii i Medycyny Transplantacyjnej.

View Article

Download full-text PDF

Source
August 2006

CD40L, CD28, and CTLA-4 expression on CD4+ T cells in kidney graft recipients: a relationship with post-transplantation clinical course.

Transpl Immunol 2006 Jun 19;16(1):32-40. Epub 2006 Apr 19.

Department of Experimental Therapy, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trim.2006.03.007DOI Listing
June 2006

The soluble CTLA-4 receptor: a new marker in autoimmune diseases.

Arch Immunol Ther Exp (Warsz) 2005 Jul-Aug;53(4):336-41

Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.

View Article

Download full-text PDF

Source
December 2005

CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region.

Arch Immunol Ther Exp (Warsz) 2004 Sep-Oct;52(5):369-74

Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.

View Article

Download full-text PDF

Source
December 2004

Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia.

Anal Quant Cytol Histol 2004 Oct;26(5):263-70

Departments of Hematology and Pathology, Medical University of Wroclaw, Wroclaw, Poland.

View Article

Download full-text PDF

Source
October 2004

[Structure and function of lymphocyte TCR/CD3 complex].

Postepy Hig Med Dosw 2003 ;57(5):519-29

Instytut Immunologii i Terapii Doświadczalnej PAN im. L. Hirszfelda we Wrocławiu.

View Article

Download full-text PDF

Source
April 2004

Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region.

Arch Immunol Ther Exp (Warsz) 2003 ;51(3):201-5

Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.

View Article

Download full-text PDF

Source
March 2004

[Intravenous immunoglobulin preparations for treatment of lymphoreticular malignancies in adults].

Authors:
Irena Frydecka

Postepy Hig Med Dosw 2002 ;56 Suppl:53-8

Zakład Terapii Doświadczalnej Instytutu Immunologii i Terapii Doświadczalnej PAN, Klinika Hematologii i Chorób Rozrostowych Akademii Medycznej we Wrocławiu.

View Article

Download full-text PDF

Source
August 2003

[Fas receptor expression on peripheral blood T lymphocytes in patients with secondary progressive multiple sclerosis].

Pol Merkur Lekarski 2003 May;14(83):421-4

Katedra i Klinika Neurologii Akademii Medycznej we Wrocławiu.

View Article

Download full-text PDF

Source
May 2003

CD28 costimulatory molecule--expression, structure and function.

Arch Immunol Ther Exp (Warsz) 2002 ;50(3):169-77

Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114 Wrocław, Poland.

View Article

Download full-text PDF

Source
December 2002

Serum levels of sTNFR-1 and sFas in patients with relapsing-remitting multiple sclerosis.

Med Sci Monit 2002 Oct;8(10):CR720-3

Department of Neurology, Medical University of Wrocław, Poland.

View Article

Download full-text PDF

Source
October 2002

Correlation of blood lymphocyte CTLA-4 (CD152) induction in Hodgkin's disease with proliferative activity, interleukin 2 and interferon-gamma production.

Br J Haematol 2002 Jul;118(1):202-9

Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2002.03572.xDOI Listing
July 2002